Cardiome Completes Enrollment in the Post Approval Safety Study SPECTRUM Evaluating Brinavess(R)
VANCOUVER, April 17, 2018 -- (Healthcare Sales & Marketing Network) - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM), a revenue-generating, specialty pharmaceutical company focused on commercializing hospital drugs, today announced completion of enrollme... Biopharmaceuticals, Cardiology Cardiome Pharma, BRINAVESS, vernakalant, atrial fibrillation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 17, 2018 Category: Pharmaceuticals Source Type: news

King-Devick technologies receives FDA clearance for K-D Balance(TM) App
This new objective balance measure utilizing a smart phone will be available in May 2018 OAKBROOK TERRACE, Ill., April 17, 2018 -- (Healthcare Sales & Marketing Network) -- King-Devick technologies, inc., a leading provider of evidence- based assessmen... Devices, FDA King-Devick Technologies, K-D Balance (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 17, 2018 Category: Pharmaceuticals Source Type: news

Xcision Announces Leading Italian Hospital to Acquire GammaPod(TM) Stereotactic Radiotherapy System for Breast Cancer
COLUMBIA, Md., April 17, 2018 -- (Healthcare Sales & Marketing Network) -- Xcision Medical Systems, LLC today announced that Azienda Universitaria Integrata di Udine (ASUIUD) in Italy will acquire the GammaPod™ Stereotactic Radiotherapy System, a new trea... Devices, Oncology Xcision Medical Systems, GammaPod, Stereotactic Radiotherapy System (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 17, 2018 Category: Pharmaceuticals Source Type: news

TELA Bio Announces Series B Investment by Checkmate Capital
Surgical reconstruction company looks to forge long-term relationship with strategic investment group. MALVERN, Pa., April 16, 2018 -- (Healthcare Sales & Marketing Network) -- TELA Bio®, Inc., a surgical reconstruction company leading the developm... Devices, Surgery, Venture Capital TELA Bio, OviTex, Reinforced BioScaffolds (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 16, 2018 Category: Pharmaceuticals Source Type: news

Apitope Announces Positive Results with Novel Treatment for Graves' Disease
Phase I data show early efficacy in the majority of patients and a very favourable safety profile HASSELT, Belgium and CHEPSTOW, Wales, April 16, 2018 -- (Healthcare Sales & Marketing Network) -- Apitope, a clinical stage biotech company developing pot... Biopharmaceuticals Apitope, Graves' Disease, Multiple Sclerosis, autoimmune disease (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 16, 2018 Category: Pharmaceuticals Source Type: news

Roche receives FDA clearance for cobas(R) CT/NG for cobas(R) 6800/8800 Systems
First moderate complexity molecular test for sexually transmitted infections on fully automated, high throughput platform Broad set of urogenital sample claims ensure greatest flexibility for patient access New test for most common sexually transmitt... Diagnostics, FDA Roche Group, cobas, cobas CT/NG, chlamydia, gonorrhoeae (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 16, 2018 Category: Pharmaceuticals Source Type: news

Cellenkos, Inc. Announces Alick Sun as Senior Vice President for Corporate and Business Development
HOUSTON, April 13, 2018 -- (Healthcare Sales & Marketing Network) -- Today, Cellenkos Inc. announced the appointment of Alick Sun as Senior Vice President for Corporate & Business Development, further strengthening its executive team as the company contin... Biopharmaceuticals, Personnel Cellenkos, cord blood, regulatory T cells, (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 13, 2018 Category: Pharmaceuticals Source Type: news

Medisystems Announces US Release of MasterGuard(R) Plus
Innovative AVF needle guard includes enhancements designed to prevent needlesticks LAWRENCE, Mass., April 13, 2018 -- (Healthcare Sales & Marketing Network) -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advan... Devices, Drug Delivery, Product Launch NxStage Medical, Medisystems, MasterGuard, needlestick, dialysis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 13, 2018 Category: Pharmaceuticals Source Type: news

Ampio Updates Regulatory, Clinical and NYSE Activities
ENGLEWOOD, Colo., April 12, 2018 -- (Healthcare Sales & Marketing Network) -- Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announces the Company has begun preliminary discussions with the Food and Drug Administration on details of the Biologics Lice... Biopharmaceuticals, FDA Ampio Pharmaceuticals, Ampion, osteoarthritis, albumin (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 13, 2018 Category: Pharmaceuticals Source Type: news

HeartStitch(R) Inc. has received CE Mark for Its Suture Based Trans-Apical Access and Closure
HeartStitch®, Inc. Announces CE Mark for its Minimally Invasive Trans-Apical Access and Closure Device ZWICKAU, Germany, April 12, 2018 -- (Healthcare Sales & Marketing Network) -- HeartStitch® Trans-Apical Access and Closure device provides sa... Devices, Cardiology, Regulatory HeartStitch, NobleStitch, vascular suture, trans-apical (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 12, 2018 Category: Pharmaceuticals Source Type: news

FDA Permits Marketing of IDx-DR for Automated Detection of Diabetic Retinopathy in Primary Care
IDx-DR becomes the first autonomous, AI-based diagnostic system authorized for marketing by the FDA CORALVILLE, Iowa, April 12, 2018 -- (Healthcare Sales & Marketing Network) -- IDx, a privately-held AI diagnostics company, announced today that the U.S... Devices, Ophthalmology, FDA, Product Launch IDx, IDx-DR, Diabetic Retinopathy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 12, 2018 Category: Pharmaceuticals Source Type: news

TransMedics, Inc. Receives FDA Pre-Market Approval (PMA) for its OCS(TM) Lung System for Near-Physiologic Preservation and Assessment of Lungs for Transplantation
ANDOVER, Mass., April 12, 2018 -- (Healthcare Sales & Marketing Network) -- TransMedics, Inc., a medical technology company that is transforming the important therapy of solid organ transplantation for patients with end-stage lung, heart and liver failure... Devices, Surgery, FDA TransMedics, Organ Care System, lung transplant, organ transplant (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 12, 2018 Category: Pharmaceuticals Source Type: news

CollPlant Appoints Revital Mandil-Levin as Chief Business Development Officer
NESS ZIONA, Israel, April 12, 2018 -- (Healthcare Sales & Marketing Network) -- CollPlant (NASDAQ: CLGN) (TASE: CLGN), a regenerative medicine company utilizing its proprietary plant-based rhCollagen technology for tissue repair products (recombinant hum... Regenerative Medicine, Personnel CollPlant, rhCollagen, Vergenix, VergenixSTR (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 12, 2018 Category: Pharmaceuticals Source Type: news

Conventus Orthopaedics Appoints Jonathan Isenburg as Chief Financial Officer
MINNEAPOLIS, April 12, 2018 -- (Healthcare Sales & Marketing Network) -- Conventus Orthopaedics, a medical device company revolutionizing fracture repair surgery, today announced the appointment of Jonathan Isenburg as its new Chief Financial Officer. Mr... Devices, Orthopaedic, Personnel Conventus Orthopaedics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 12, 2018 Category: Pharmaceuticals Source Type: news

Elekta Expands the MOSAIQ Ecosystem of Complementary Applications With Strategic Investment in PalabraApps
Enhanced collaboration designed to advance Elekta's clinical workflow productivity and mobility offerings ATLANTA, April 12, 2018 -- (Healthcare Sales & Marketing Network) -- Elekta (EKTA-B.ST) today announced that it is making a strategic investment i... Devices, Oncology, Venture Capital Elekta, PalabraApps, MOSAIQ, radiotherapy, radiosurgery (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 12, 2018 Category: Pharmaceuticals Source Type: news

Genprex Appoints Julien Pham, MD, MPH As President To Lead Commercialization Of Oncoprex Immunogene Therapy
AUSTIN, Texas and CAMBRIDGE, Mass., April 11, 2018 -- (Healthcare Sales & Marketing Network) -- Genprex, Inc. (NASDAQ: GNPX), a clinical stage gene therapy company developing a new approach to treating cancer based upon a novel proprietary technology plat... Biopharmaceuticals, Oncology, Drug Delivery, Personnel Genprex, Oncoprex, immunogene therapy, non-small cell lung cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 11, 2018 Category: Pharmaceuticals Source Type: news

RubrYc Therapeutics Completes $10M Million Series A Financing
SAN RAMON, Calif., April 11, 2018 -- (Healthcare Sales & Marketing Network) -- RubrYc Therapeutics, Inc., a biotherapeutics discovery business, announced today it has closed a $10 million Series A Preferred Equity financing round led by Third Point Ventur... Biopharmaceuticals, Venture Capital RubrYc Therapeutics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 11, 2018 Category: Pharmaceuticals Source Type: news

InMed Announces Appointment of Joshua Blacher as Chief Business Officer
VANCOUVER, April 11, 2018 -- (Healthcare Sales & Marketing Network) - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQB: IMLFF), a biopharmaceutical company specializing in the research and development of novel, cann... Biopharmaceuticals, Drug Delivery, Personnel InMed Pharmaceuticals, cannabinoid (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 11, 2018 Category: Pharmaceuticals Source Type: news

ACell, Inc. Announces Launch of Gentrix(R) Incisional
Extracellular Matrix Device Designed to Reinforce Soft Tissue in a Range of Implantable Settings COLUMBIA, Md., April 11, 2018 -- (Healthcare Sales & Marketing Network) -- ACell, Inc. today announced the introduction of Gentrix Incisional, a new implan... Devices, Surgery, Product Launch ACell , Gentrix Incisional, MatriStem, MatriStem UBM (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 11, 2018 Category: Pharmaceuticals Source Type: news

Sysmex Inostics: OncoBEAM(TM) RAS CRC Liquid Biopsy Test Now Reimbursed in Germany by BARMER
HAMBURG, Germany, April 11, 2018 -- (Healthcare Sales & Marketing Network) -- Colorectal cancer patients in Germany insured by BARMER are now covered for the OncoBEAM RAS CRC IVD Test, an innovative liquid biopsy diagnostic that delivers a comprehensive e... Diagnostics, Oncology, Reimbursement Sysmex Inostics, OncoBEAM, RAS mutation, colorectal cancer, liquid biopsy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 11, 2018 Category: Pharmaceuticals Source Type: news

Somatus Raises $11 Million in Series B Financing
Innovative Kidney Care Company works with Health Systems and Payers to enable value-based care for CKD and ESRD populations VIENNA, Va., April 11, 2018 -- (Healthcare Sales & Marketing Network) -- Somatus, an innovative care delivery and management com... Devices, Venture Capital Somatus, Chronic Kidney Disease, End Stage Renal Disease, dialysis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 11, 2018 Category: Pharmaceuticals Source Type: news

Macrophage Pharma Appoints Dr Michael Moore as Chairman
WINDSOR, England, April 11, 2018 -- (Healthcare Sales & Marketing Network) -- Macrophage Pharma Limited ('MPL'), a company focused on the discovery and development of next-generation small molecules aiming to modulate immune responses to combat cancer and... Biopharmaceuticals, Personnel Macrophage Pharma, Esterase Motif Technology (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 11, 2018 Category: Pharmaceuticals Source Type: news

Wound Management Technologies Changes Name to WNDM Medical
New name better reflects breadth of products and long-term vision for growth FORT WORTH, Texas (April 10, 2018) -- (Healthcare Sales & Marketing Network) -- Wound Management Technologies Inc. announced today that it is changing its name to WNDM Medical ... Devices, Surgery, Wound Care WNDM Medical, Wound Management Technologies (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 10, 2018 Category: Pharmaceuticals Source Type: news

Geistlich Bio-Gide(R) Portfolio Expands
The Collagen Expert, Geistlich Biomaterials Launches Two NEW Resorbable Collagen Membranes to Enhance Clinical Procedures PRINCETON, N.J., April 10, 2018 -- (Healthcare Sales & Marketing Network) -- Geistlich Pharma North America, Inc., introduces Gei... Devices, Dental, Product Launch Geistlich Pharma, Bio-Gide, collagen membrane (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 10, 2018 Category: Pharmaceuticals Source Type: news

TCR2 Therapeutics Appoints Leading Biotech Analyst Ian Somaiya as Chief Financial Officer
CAMBRIDGE, Mass., April 10, 2018 -- (Healthcare Sales & Marketing Network) -- TCR2 Therapeutics Inc., an immuno-oncology company pioneering a novel class of T cell receptor (TCR)-based cellular therapies for solid tumors and blood cancers, announced today... Biopharmaceuticals, Oncology, Personnel TCR2 Therapeutics, TRuC , immunotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 10, 2018 Category: Pharmaceuticals Source Type: news

Mylan to Acquire the Global Marketing Rights to a Once-monthly Glatiramer Acetate Product through an Investment and Partnership with Israeli Company Mapi Pharma
Once approved, this product could represent a significant milestone for patients with relapsing-remitting multiple sclerosis Mapi Pharma has completed an open-label Phase II clinical trial and is preparing to commence a pivotal Phase III clinical trial ... Biopharmaceuticals, Neurology, Acquisitions Mylan, Mapi Pharma, GA Depot, Glatiramer, multiple sclerosis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 10, 2018 Category: Pharmaceuticals Source Type: news

Former CoLucid CEO Thomas P. Mathers joins Pappas Capital as Partner
RESEARCH TRIANGLE PARK, N.C., April 10, 2018 -- (Healthcare Sales & Marketing Network) -- Pappas Capital announced today that Thomas P. "Tom" Mathers has joined the firm as a partner. Mathers previously served as CEO of CoLucid Pharmaceuticals (... Biopharmaceuticals, Venture Capital, Personnel Pappas Capital (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 10, 2018 Category: Pharmaceuticals Source Type: news

Cumberland Pharmaceuticals Expands into Oncology Support
FDA-approved Ethyol® and Totect® address harmful effects of cancer treatments to help improve the quality of life for oncology patients NASHVILLE, Tenn., April 9, 2018 -- (Healthcare Sales & Marketing Network) -- Cumberland Pharmaceuticals – an... Biopharmaceuticals, Oncology, Licensing, Distribution Cumberland Pharmaceuticals, Ethyol, Totect (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 9, 2018 Category: Pharmaceuticals Source Type: news

Fischer Medical Receives U.S. FDA 510(k) Clearance to Market Bloom2 Cardiac Stimulator
DENVER, April 9, 2018 -- (Healthcare Sales & Marketing Network) -- Fischer Medical has announced that the Bloom2 cardiac electrophysiology stimulator device has received U.S. Food and Drug Administration (FDA) 510(k) clearance. The Bloom2 stimulator is a... Devices, Cardiology, FDA Fischer Medical, Bloom2, Cardiac Stimulator, electrophysiology (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 9, 2018 Category: Pharmaceuticals Source Type: news

Intezyne Promotes Adam Carie, PhD to Director, Product Development
TAMPA, Fla., April 9, 2018 -- (Healthcare Sales & Marketing Network) -- Intezyne, a clinical-stage biopharmaceutical company developing novel anti-cancer therapies, announced that it has promoted Adam Carie, PhD to Director, Product Development. In his ne... Biopharmaceuticals, Oncology, Personnel Intezyne Technologies, Cancer Resistance Pathway, topoisomerase (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 9, 2018 Category: Pharmaceuticals Source Type: news

Natera Appoints Paul R. Billings, M.D., Ph.D., as Chief Medical Officer
Leading authority on genomics and diagnostics in medical practice will help Natera's efforts in advancing individualized genomic medicine SAN CARLOS, Calif., April 9, 2018 -- (Healthcare Sales & Marketing Network) -- Natera (NASDAQ: NTRA), a leader in ... Diagnostics, Personnel Natera, cell-free DNA (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 9, 2018 Category: Pharmaceuticals Source Type: news

Omnicell Appoints Scott Seidelmann as Chief Commercial Officer
New Role will Focus on Emerging Digital Health Technologies and Supporting Customer and Market Needs MOUNTAIN VIEW, Calif., April 9, 2018 -- (Healthcare Sales & Marketing Network) -- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and s... Devices, Personnel Omnicell, supply management (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 9, 2018 Category: Pharmaceuticals Source Type: news

RegeneRx Announces Outcome of FDA Discussions for Development of RGN-259 for Dry Eye Syndrome
ROCKVILLE, Md., April 9, 2018 -- (Healthcare Sales & Marketing Network) -- RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the Company" or "RegeneRx"), a clinical-stage drug development company focused on tissue protection, repair an... Biopharmaceuticals, Ophthalmology, FDA RegeneRx Biopharmaceuticals, ReGenTree, Dry Eye (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 9, 2018 Category: Pharmaceuticals Source Type: news

Elekta Strengthens Presence in Mexico With Government Tender for Radiation Therapy Technology
Elekta further invests in Mexico with new offices and fortified workforce MEXICO, April 9, 2018 -- (Healthcare Sales & Marketing Network) -- Elekta (EKTA-B.ST) announced today that it has won a government tender to supply Instituto Mexicano del Seguro ... Devices, Oncology Elekta, Elekta Synergy, Elekta Infinity, linear accelerator, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 9, 2018 Category: Pharmaceuticals Source Type: news

Teligent, Inc. Announces FDA Approval of Ciclopirox Shampoo, 1%
BUENA, N.J., April 06, 2018 -- (Healthcare Sales & Marketing Network) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s abbreviated new drug application (... Biopharmaceuticals, Generics, FDA Teligent, Ciclopirox Shampoo, Ciclopirox (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 6, 2018 Category: Pharmaceuticals Source Type: news

Impax Launches a Generic Version of Estrace(R) Cream (estradiol vaginal cream, USP, 0.01%)
BRIDGEWATER, N.J., April 6, 2018 -- (Healthcare Sales & Marketing Network) -- Impax Laboratories, Inc. (NASDAQ: IPXL), a specialty pharmaceutical company, today announced it has launched a generic version of Estrace® Cream (estradiol vaginal cream, US... Biopharmaceuticals, Generic, Product Launch Impax Laboratories, Perrigo Company, Estrace Cream, estradiol vaginal cream (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 6, 2018 Category: Pharmaceuticals Source Type: news

Former Acelity, JandJ Executive Joins Organogenesis as Vice President of Global Medical and Clinical Affairs
Dr. Shabnam Vaezzadeh Joins Organogenesis Leadership Team in Strategic Medical Direction Role CANTON, Mass., April 5, 2018 -- (Healthcare Sales & Marketing Network) -- Shabnam Vaezzadeh, MD, MPA, formerly of Acelity, KCI, and Johnson & Johnson LifeScan... Regenerative Medicine, Personnel Organogenesis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 5, 2018 Category: Pharmaceuticals Source Type: news

AbbVie Announces Global Resolution of HUMIRA(R) (adalimumab) Patent Disputes with Samsung Bioepis
Agreements Provide Non-Exclusive License to Samsung Bioepis for HUMIRA-Related Intellectual Property in the U.S. Effective June 30, 2023, and in Other Markets on Different Dates Samsung Bioepis Acknowledges Validity of AbbVie's Intellectual Property for... Biopharmaceuticals, Litigation, Licensing AbbVie, Samsung Bioepis, biosimilar, HUMIRA, adalimumab (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 5, 2018 Category: Pharmaceuticals Source Type: news

Eidos Therapeutics completes $64M Series B financing
Funding supports Phase 2 clinical trials of AG10, a potential best-in-class therapy for transthyretin amyloidosis, and ongoing preparation for Phase 3 clinical trials SAN FRANCISCO, April 5, 2018 -- (Healthcare Sales & Marketing Network) -- Eidos Thera... Biopharmaceuticals, Venture Capital Eidos Therapeutics, transthyretin amyloidosis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 5, 2018 Category: Pharmaceuticals Source Type: news

Arvinas Completes $55 Million Series C Financing to Advance Protein Degradation Platform
Financing round led by Nextech Invest Proceeds to advance lead oncology programs into the clinic and broaden early-stage pipeline NEW HAVEN, Conn., April 4, 2018 -- (Healthcare Sales & Marketing Network) -- Arvinas LLC, a private biotechnology compa... Biopharmaceuticals, Venture Capital, Personnel Arvinas, Proteolysis Targeting Chimeras (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 4, 2018 Category: Pharmaceuticals Source Type: news

Abide Therapeutics Appoints Thomas C. Südhof to Board of Directors
SAN DIEGO, April 4, 2018 -- (Healthcare Sales & Marketing Network) -- Abide Therapeutics, a clinical-stage biopharmaceutical company focused on developing novel therapeutics targeting the serine hydrolase family of enzymes with an emphasis on CNS disorder... Biopharmaceuticals, Personnel Abide Therapeutics, serine hydrolase (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 4, 2018 Category: Pharmaceuticals Source Type: news

Lilly and Sigilon Therapeutics Announce Strategic Collaboration to Develop Encapsulated Cell Therapies for the Treatment of Type 1 Diabetes
Sigilon's Afibromer technology will be used to encapsulate insulin-producing cells for the potential treatment of type 1 diabetes Sigilon to receive upfront payment of $63 million and undisclosed equity investment INDIANAPOLIS and CAMBRIDGE, Mass., A... Biopharmaceuticals, Endocrinology, Licensing Eli Lilly, Sigilon Therapeutics, encapsulated cell therapies, diabetes (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 4, 2018 Category: Pharmaceuticals Source Type: news

Angus Russell to Succeed Melvin Booth as Mallinckrodt Chairman of the Board in May 2018
Booth announces retirement; Director Diane Gulyas also to retire from Board in May 2018 STAINES-UPON-THAMES, United Kingdom, April 4, 2018 -- (Healthcare Sales & Marketing Network) -- Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceuti... Biopharmaceuticals, Personnel Mallinckrodt (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 4, 2018 Category: Pharmaceuticals Source Type: news

Mallinckrodt Names Paul R. Carter, Anne C. Whitaker to its Board of Directors
Both to become independent directors pending May 2018 Annual General Meeting approval STAINES-UPON-THAMES, United Kingdom, April 4, 2018 -- (Healthcare Sales & Marketing Network) -- Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutica... Biopharmaceuticals, Personnel Mallinckrodt (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 4, 2018 Category: Pharmaceuticals Source Type: news

Proteostasis Therapeutics Receives FDA Fast Track Designation for Triple Combination Program in Patients with Cystic Fibrosis
CAMBRIDGE, Mass., April 4, 2018 -- (Healthcare Sales & Marketing Network) -- Proteostasis Therapeutics, Inc. (NASDAQ: PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic f... Biopharmaceuticals, FDA Proteostasis Therapeutics, transmembrane conductance regulator, cystic fibrosis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 4, 2018 Category: Pharmaceuticals Source Type: news

Improving Cardiology Care: BIOTRONIK US to Distribute Aziyo ECM Envelopes
BioEnvelope Reduces Scarring, Improves Device Stability LAKE OSWEGO, Ore. and SILVER SPRING, Md., April 3, 2018 -- (Healthcare Sales & Marketing Network) -- BIOTRONIK US and Aziyo today announced a strategic agreement allowing BIOTRONIK to distribute A... Devices, Cardiology, Distribution BIOTRONIK, Aziyo Biologics, CanGaroo (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 3, 2018 Category: Pharmaceuticals Source Type: news

Oncternal Therapeutics Further Strengthens Leadership with Additions to Board of Directors
William R. LaRue and Charles Theuer, M.D., Ph.D., Bring Broad Experience in Executive Leadership, Corporate Finance and Oncology Drug Development SAN DIEGO, April 3, 2018 -- (Healthcare Sales & Marketing Network) -- Oncternal Therapeutics, Inc., a cli... Biopharmaceuticals, Oncology, Personnel Oncternal Therapeutics, cirmtuzumab (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 3, 2018 Category: Pharmaceuticals Source Type: news

Dr. Ottavio Vitolo Joins Relmada Therapeutics as Senior Vice President, Head of RandD and Chief Medical Officer
Dr. Vitolo brings wide range of experience in clinical psychiatry, neurology and rare diseases to lead Relmada development programs NEW YORK, April 3, 2018 -- (Healthcare Sales & Marketing Network) -- Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinica... Biopharmaceuticals, Personnel Relmada Therapeutics, methadone, mepivacaine, dextromethadone (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 3, 2018 Category: Pharmaceuticals Source Type: news

Bridge Medicines Appoints Louis M. Renzetti, Ph.D., As Chief Scientific Officer
NEW YORK, April 3, 2018 -- (Healthcare Sales & Marketing Network) -- Bridge Medicines, a pioneering drug discovery company focused on advancing promising early technologies from concept to clinic, announced today the appointment of Louis M. Renzetti, Ph.D... Biopharmaceuticals, Personnel Bridge Medicines (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 3, 2018 Category: Pharmaceuticals Source Type: news

FDA Approves GORE(R) CARDIOFORM Septal Occluder for PFO Closure to Prevent Recurrent Ischemic Stroke
Gore REDUCE Clinical Study demonstrated 77 percent relative reduction in recurrent ischemic stroke when PFO closure was combined with antiplatelet therapy, compared to antiplatelet therapy alone FLAGSTAFF, Ariz., April 3, 2018 -- (Healthcare Sales & Mar... Devices, Interventional, Cardiology, FDA W. L. Gore, patent foramen ovale, CARDIOFORM, Septal Occluder (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 3, 2018 Category: Pharmaceuticals Source Type: news